Revolution Medicines, Inc.

Bank of New York Mellon Corp RVMD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

542,069

Value ($000)

43,176

Weight

0.0%

2020 Q1 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	43,176	0.0%	542,069	12/31/2025
2025 Q3	11/3/2025	24,717	0.0%	529,270	9/30/2025
2025 Q2	8/5/2025	18,197	0.0%	494,613	6/30/2025
2025 Q1	4/29/2025	20,605	0.0%	582,721	3/31/2025
2024 Q4	2/4/2025	24,889	0.0%	569,015	12/31/2024
2024 Q3	11/12/2024	24,140	0.0%	532,310	9/30/2024
2024 Q2	7/25/2024	25,042	0.0%	645,253	6/30/2024
2024 Q1	4/25/2024	17,063	0.0%	529,409	3/31/2024
2023 Q4	1/29/2024	16,669	0.0%	581,216	12/31/2023
2023 Q3	10/24/2023	11,636	0.0%	420,366	9/30/2023
2023 Q2	8/3/2023	11,009	0.0%	411,541	6/30/2023
2023 Q1	5/9/2023	6,338	0.0%	292,611	3/31/2023
2022 Q4	2/14/2023	6,176	0.0%	259,268	12/31/2022
2022 Q3	11/14/2022	5,085	0.0%	257,865	9/30/2022
2022 Q2	8/15/2022	3,859	0.0%	198,011	6/30/2022
2022 Q1	5/11/2022	6,679	0.0%	261,808	3/31/2022
2021 Q4	2/11/2022	6,759	0.0%	268,557	12/31/2021
2021 Q3	11/18/2021	7,379	0.0%	268,215	9/30/2021
2021 Q2	8/11/2021	7,371	0.0%	232,234	6/30/2021
2021 Q1	5/13/2021	6,511	0.0%	141,902	3/31/2021
2020 Q4	2/9/2021	5,440	0.0%	137,409	12/31/2020
2020 Q3	11/12/2020	4,501	0.0%	129,360	9/30/2020
2020 Q2	8/12/2020	1,767	0.0%	55,956	6/30/2020
2020 Q1	5/6/2020	856	0.0%	39,068	3/31/2020